Amgen Inc. (AMGN) vs Gilead Sciences, Inc. (GILD)
A side-by-side comparison of Amgen Inc. and Gilead Sciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
AMGN
Amgen Inc.
$393.10HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
GILD
Gilead Sciences, Inc.
$134.32HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
Total return — AMGN vs GILD
growth of $100 · dividends reinvested · last 30yAMGN +4319.8%GILD +33159.4%GILD compounded faster
Log scale — wide-divergence pair
AMGN GILD
AMGN vs GILD: by the numbers
- •AMGN is the larger company ($212.16B vs $166.77B market cap).
- •GILD trades at the lower trailing earnings multiple (17.78 vs 26.18 P/E), one valuation lens rather than an overall verdict.
- •GILD converts more revenue to profit (30.99% vs 20.95% net margin).
- •AMGN grew revenue faster over the past five years (8.15% vs 3.07% CAGR).
- •AMGN pays the higher dividend yield (2.60% vs 2.47%).
Metrics side by side
Valuation
| Metric | AMGN | GILD |
|---|---|---|
| P/E ratio | 26.18 | 17.78 |
| Forward P/E | 16.84 | N/A |
| P/S ratio | 5.50 | 5.50 |
| P/B ratio | 22.27 | 6.96 |
| PEG ratio | 0.26 | 0.01 |
| EV / EBITDA | 14.99 | 12.61 |
| FCF yield | 4.20% | 6.25% |
Profitability
| Metric | AMGN | GILD |
|---|---|---|
| Gross margin | 71.46% | 79.35% |
| Operating margin | 31.63% | 38.26% |
| Net margin | 20.95% | 30.99% |
| ROE | 84.87% | 39.19% |
| ROIC | 13.16% | 21.53% |
Dividends
| Metric | AMGN | GILD |
|---|---|---|
| Dividend yield | 2.60% | 2.47% |
| Payout ratio | 68.39% | 47.08% |
Growth (annualized)
| Metric | AMGN | GILD |
|---|---|---|
| Revenue CAGR (5Y) | 8.15% | 3.07% |
| EPS CAGR (5Y) | 2.94% | 133.83% |
| FCF CAGR (5Y) | -2.66% | 3.30% |
| Total return CAGR (5Y) | 13.52% | 18.02% |
Frequently asked
- Which has the lower trailing P/E, AMGN or GILD?
- GILD has the lower trailing P/E: AMGN trades at 26.18 and GILD at 17.78. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, AMGN or GILD?
- Over the past five years, AMGN grew revenue faster — AMGN at a 8.15% CAGR versus GILD at 3.07%.
- Does AMGN or GILD pay a bigger dividend?
- AMGN yields 2.60% and GILD yields 2.47% based on trailing dividends and the latest price.
- Is AMGN or GILD more profitable?
- GILD runs the higher net margin — AMGN at 20.95% versus GILD at 30.99%.
- How have AMGN and GILD total returns compared?
- Over the past 10 years, AMGN delivered 11.95% and GILD delivered 8.90% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Amgen P/E ratioGilead Sciences P/E ratioAmgen dividend yieldGilead Sciences dividend yieldAmgen ROEGilead Sciences ROEAmgen operating marginGilead Sciences operating marginAmgen revenue growthGilead Sciences revenue growthAmgen free cash flowGilead Sciences free cash flow
Amgen & Gilead Sciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.